SRI

Stoneridge is a deep-value, deeply-troubled auto-parts cyclical. At $6.93 the $194M market cap trades at just 0.2x sales and essentially at book — stockholders' equity is $180M ($6.43/share). That optical cheapness is the entire bull case, and it exists because the business is genuinely deteriorating: revenue has now fallen three straight years off the 2023 peak ($976M → $861M, -5.2% in FY2025), and the company swung from a roughly breakeven operation to a -$38.6M operating loss. Management ties this to 'lower production volumes at our customers from lower demand in most of our served markets' across its cyclical commercial, off-highway and agricultural end markets, which are 93% of sales.

The headline -$102.8M net loss (EPS -$3.70) looks worse than the cash reality. Per the MD&A, it is inflated by two large non-cash/non-recurring items — 'a valuation allowance for U.S. federal deferred tax assets and the impairment of fixed assets in our Control Devices segment' — plus SG&A tied to 'Control Devices strategic alternatives' and realignment costs. Crucially, the company still generated $34.0M of operating cash flow (against $21.9M capex), and used it to cut Credit Facility borrowings from $201.6M to $180.9M. Liquidity is not in crisis: $66.3M cash, current assets $362M vs. current liabilities $158M (~2.3x), and debt roughly matched by equity. This is a survivor, not a zero.